Billionaire hedge funder Jim Chanos is still short Valeant
Reuters
"I'm still short Valeant," Chanos said in an interview with CNBC at the Sohn Conference on Friday.
The pharmaceutical company is a former stock market darling that's been hit with SEC investigations, Senate investigations, and a precipitous decline in its stock price.
Chanos said that everybody is using metrics that are "just as bad as Valeant's accounting."
Hedge fund manager Bill Ackman, who is long Valeant, on Monday told CNBC he hopes to turn the company around.
Ackman joined Valeant's board in March as the company's CEO, Mike Pearson, announced his departure from the firm.
Valeant's stock has plunged about 86% in the past year and almost 70% since October.
More to come...
NOW WATCH: How ISIS makes over $1 billion a year
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status